03/17/23 6:30 AMAMEX : ZOM managementZomedica Appoints New Chief Financial OfficerZomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Peter L. Donato as its Chief FinancialRHEA-AIvery positive
03/15/23 4:45 PMAMEX : ZOM acquisitionZomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growthZomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported consolidated financial results for the year ended DecemberRHEA-AIpositive
03/08/23 6:30 AMAMEX : ZOM conferencesearningsZomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Wednesday, March 15, at 4:30 p.m. ETRHEA-AIneutral
02/09/23 6:30 AMAMEX : ZOM Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported its preliminary unaudited results for the fourth quarterRHEA-AIneutral
02/08/23 4:15 PMAMEX : ZOM Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R)RedChip Companies will air a new interview with Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company") on The RedChip Money Report® on Bloomberg TV, this Saturday, February 11, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimatedRHEA-AIneutral
01/24/23 6:00 AMAMEX : ZOM conferencesZomedica to Participate in the Lytham Partners Investor Select ConferenceZomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company") announced today that the Company will be participating in the Lytham Partners Investor Select Conference taking place virtually on January 31, 2023. Company Webcast The Company's webcastRHEA-AIneutral
01/18/23 6:00 AMAMEX : ZOM Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo BiotechnologiesZomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced a strategic restructuring of its existing development andRHEA-AIpositive
01/17/23 6:00 AMAMEX : ZOM Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless MonitorsZomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that in cooperation with Structured Monitoring Products, Inc. (SMP), itRHEA-AIpositive
01/11/23 6:00 AMAMEX : ZOM conferencesZomedica to Present at Sidoti Virtual Investor Conference January 18-19Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced Larry Heaton, CEO, will present and host one-on-one meetings withRHEA-AIneutral
12/15/22 6:30 AMAMEX : ZOM Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and PlansZomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announces an update interview with the Wall Street Analyzer, and LarryRHEA-AIvery positive